The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib, open-label, multi-cohort study of metronomic capecitabine plus camrelizumab for treatment of refractory solid tumor: McCrest trial.
 
Chenfei Zhou
No Relationships to Disclose
 
Chengfang Shangguan
No Relationships to Disclose
 
Wenqi Xi
No Relationships to Disclose
 
Hui Yang
No Relationships to Disclose
 
Liting Guo
No Relationships to Disclose
 
Min Shi
No Relationships to Disclose
 
Qu Cai
No Relationships to Disclose
 
Jun Ji
No Relationships to Disclose
 
Yan Shi
No Relationships to Disclose
 
Jing Liu
No Relationships to Disclose
 
Zhenggang Zhu
No Relationships to Disclose
 
Jun Zhang
Speakers' Bureau - Bristol-Myers Squibb; Genecast; HenRui; Merck; MSD; Pfizer; Roche; Sanofi